We have something very exciting to announce.
Omics AI (https://t.co/sxAiE9Kj1Z) is a revolutionary software suite that gives scientists the power to derive insights across global networks of omics and health data.
https://t.co/S18ronyv1t
HiFi sequencing can reveal rare and complex variants, but interpretation requires diverse background datasets.
PacBio and @DNAstack are supporting the first global federated dataset of HiFi whole genomes through the HiFi Solves Global Consortium.
Info: https://t.co/6pGZmrxHuX
Our partner @DNAstack just launched Questions, now powering projects like #HiFiSolves with #PacBio HiFi sequencing.
Read the news here 👇https://t.co/rEypnE2Wyu
@TargetALS_fdn@DNAstack@Verily Well done, Target. We have learned that our openly sharing data and cell samples from 1100 participants that has resulted in more than 350 ongoing studies since launching our data portal has been critical to ALS research progress. Keep it going.
@DNAstack@alsadvocacy@AnswerALS@ALSTDI Access to big datasets dramatically accelerates novel discoveries & treatments for ALS. With @DNAstack's technology, our portal allows for data sharing & we welcome convergence where possible. We're also participating in AMP-ALS to bring ALS datasets together into one portal.
Partnering with @DNAstack helps support Vector’s mission to drive excellence and leadership in Canada’s knowledge, creation, and use of responsible and trustworthy AI (2/2)
Le partenariat avec @DNAstack contribue à soutenir la mission de Vecteur, qui consiste à favoriser l'excellence et le leadership dans la connaissance, la création et l'utilisation d'une IA responsable et digne de confiance au Canada (2/2).
The Natural History Study Collection is now available on the @TargetALS_fdn Data Portal, created in collaboration with @DNAstack & @Verily. Access data from our ongoing study to drive biomarker & target discovery for #ALS. https://t.co/1fNAWhMCOQ
#ALSResearch#EndALS
This collaboration will integrate cutting-edge AI/ML technologies with our platform for standards-compliant and privacy-preserving federated insights. It's about making powerful discoveries in a way that is fast and safe.
🧬Breaking global barriers in health research! We are thrilled to announce our newest sponsor @DNAstack, the pioneers in creating and analyzing global federated networks of genetic data in line with industry standards by the Global Alliance for Genomics & Health. (½)
ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. Symptoms may be mild at first and include muscle weakness, twitching, cramping, or stiffness. People may lose the ability to move, speak, swallow, and, eventually, breathe.
Today, we're thrilled to celebrate a groundbreaking initiative that is accelerating the search for effective treatments for Amyotrophic Lateral Sclerosis (ALS).
We're proud to partner with @TargetALS_fdn to launch their brand new data portal to provide no-strings-attached access to comprehensive datasets and analysis tools to fuel ALS research.
In collaboration with @DNAstack and @Verily, Target ALS has launched a first-of-its-kind data portal that will provide no-strings-attached access to comprehensive datasets and analysis tools to fuel the discovery of treatments and biomarkers for #ALS.
https://t.co/KZdvaJKSu6
In collaboration with @DNAstack and @Verily, Target ALS has launched a first-of-its-kind data portal that will provide no-strings-attached access to comprehensive datasets and analysis tools to fuel the discovery of treatments and biomarkers for #ALS.
https://t.co/KZdvaJKSu6